A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects

Stopped This study was terminated early due to neuropsychiatric serious adverse events reported by 2 participants.

Conditions

• Infection, Human Immunodeficiency Virus

Interventions

• DRUG: BMS-955176, Placebo (Part 1)
• DRUG: BMS-955176, Moxifloxacin, Placebo (Part 2)

Sponsor

ViiV Healthcare

Collaborators

• [object Object]